-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The building blocks of the structure are made up of load-bearing elements that are rarely altered even when refurbished or repaired
Bones are dynamic: they are constantly breaking down and rebuilding to become the strongest of their own
Mutations in this bone regeneration process can cause bones to become fragile, and if this mutation is related to the amount of collagen produced in bones, connective tissue, skin, and cartilage, it can lead to fragile bone disease
Fragile bone disease, also known as osteogenesis imperfecta, currently affects 20,000 to 50,000 people in the United States, but it is also the most common inherited bone disease
Her goal is to find a safer way to treat this devastating disease
Mehrotra says healthy bones are constantly experiencing and reshaping their micro-fractures
There is a drug called bisphosphate that is currently being used to treat brittle bone disease
In a recent paper, iScience, the research team used regulatory T cells (Treg cells) as a previously unmet treatment for fragile bone disease
They found that the internal environment of mice with the disease was overinflamed
With Treg transplants, the researchers demonstrated that increasing the number of Tregs does promote bone remodeling, which makes bones stronger
Mehrotra and her team tested Treg cell transplantation with T cells from the affected mice themselves (autologous transplantation) and T cells from donor mice (allogeneic transplantation) and compared the results
In two transplants, Mehrotra found an increase in the number of osteoblasts and a decrease in the number of osteoclasts
But the part that excites her the most is that while both allogeneic and autologous transplants are effective, autologous transplants yield better
After studying hematopoietic stem cells and brittle bone disease in previous studies, Mehrotra came up with the idea
Next, she wanted to see why a genetic disease with a collagen mutation seemed to have nothing to do with immunity, but it had immunodeficiency
.
Then she wanted to see how increasing Treg had a positive effect on the
bones.
"For me, that's another puzzle," she said
.
Answering these two questions will help bring Treg cell transplants closer to the clinic for people with brittle bone disease
.
Quantitative increase in T regulatory cells enhances bone remodeling in osteogenesis imperfecta